Low pretreatment testosterone levels have been associated with poorer outcome following radical prostatectomy (RP) for prostate cancer in some studies, although other studies found conflicting results ...

A typical prostate is about the size of a walnut, but prostate enlargement is common with age. The prostate is a part of the reproductive system. It’s a small gland positioned in front of the rectum, ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Improving imaging processes will lead to more successful treatments and help reduce morbidity in men with the disease. A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has ...

Magnetic resonance imaging (MRI) is often used in the diagnosis and management of prostate cancer, but the method frequently underestimates tumor size, a study in the Journal of Urology shows.

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading ...

Introduction Health-related quality of life (HRQOL) is a legitimate construct for evaluating treatment and its side effects. Recently, predictive value of HRQOL on survival also has been of interest.

A new editorial paper was published in Oncotarget's Volume 15 on July 2, 2024, entitled, "Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration ...

With growing age, many experience Benign Prostatic Hyperplasia (BPH) also known as an enlarged prostate. Research indicates that prostate enlargement affects 25% of men during their 50s but this ...

Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane. This is an ASCO ...